Biosimilar Market Formation Isn't Going According To Plan
As user fee negotiations begin, FDA has far more sponsors in product development phase and far fewer marketing applications than anticipated.
As user fee negotiations begin, FDA has far more sponsors in product development phase and far fewer marketing applications than anticipated.